Chandra Prakash Prasad

ResearcherID Loop profile ORCID

Publication Activity (10 Years)

Years Active: 2016-2024
Publications (10 Years): 13

Top Venues

Cell biology international

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Vaccines

Journal of experimental & clinical cancer research : CR

All India Institute of Medical Sciences

Guru Gobind Singh Indraprastha University (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

All India Institute of Medical Sciences Nov 09 2016

India

Assistant Professor :: Medical Oncoloy (Lab)

Lunds universitet Medicinska fakulteten Mar 01 2014

Sweden

Laboratory Investigator :: Translational Medicine, Experimental Pathology

Lunds universitet Medicinska fakulteten Mar 01 2010 - Feb 28 2014

Sweden

Post Doc Researcher :: Translational Medicine, Experimental Pathology

Education History

Guru Gobind Singh Indraprastha University Oct 01 2005 - Mar 08 2011

India

PHD :: Faculty of medical & para-medical health Sciences

University of Delhi Ram Lal Anand College Jun 01 1997 - May 01 2000

India

BSC :: Microbiology

Publications

Akhil Santhosh, Vinod Sharma, Sameer Bakhshi, Akash Jha, Vinod Sharma, Prabhat Singh Malik, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Tushar Sehgal, Sneha Gund, Arundhathi Dev, Winson Y Cheung, R M Pandey, Saran Kumar, Ishaan Gupta, Atul Batra, null null
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Sheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, Meetu Rathee, Shyam S Chauhan, Atul Sharma, Chandra Prakash Prasad
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cells. Cell biology international 48 (8) (2024)
Akhil Santhosh, Vinod Sharma, Sameer Bakhshi, Akash Jha, Vinod Sharma, Prabhat Singh Malik, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Tushar Sehgal, Sneha Gund, Arundhathi Dev, Winson Y Cheung, R M Pandey, Saran Kumar, Ishaan Gupta, Atul Batra, null null
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Akhil Santhosh, Vinod Sharma, Sameer Bakhshi, Akash Jha, Vinod Sharma, Prabhat Singh Malik, Raja Pramanik, Ajay Gogia, Chandra Prakash Prasad, Tushar Sehgal, Sneha Gund, Arundhathi Dev, Winson Y Cheung, R M Pandey, Saran Kumar, Ishaan Gupta, Atul Batra, null null
Topical Diclofenac for Prevention of Capecitabine-Associated Hand-Foot Syndrome: A Double-Blind Randomized Controlled Trial. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (15) (2024)
Sheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, Meetu Rathee, Shyam S Chauhan, Atul Sharma, Chandra Prakash Prasad
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cells. Cell biology international (2024)
Sheikh Mohammad Umar, Arundhathi J R Dev, Akanksha Kashyap, Meetu Rathee, Shyam S Chauhan, Atul Sharma, Chandra Prakash Prasad
7-amino carboxycoumarin 2 inhibits lactate induced epithelial-to-mesenchymal transition via MPC1 in oral and breast cancer cells. Cell biology international 48 (8) (2024)
Abhinava K Mishra, Ashna Gupta, Gunjan Dagar, Dayasagar Das, Abhishek Shankar, Shabirul Haque, Chandra Prakash Prasad, Archana Singh, Ajaz Ahmad Bhat, Muzafar A Macha, Moez Benali, Kamal S Saini, Rebecca Ann Previs, Deepak Saini, Dwaipayan Saha, Preyangsee Dutta, Aseem Rai Bhatnagar, Mrinalini Darswal, Abhishek Shankar, Mayank Singh
CAR-T-Cell Therapy in Multiple Myeloma: B-Cell Maturation Antigen (BCMA) and Beyond. Vaccines 11 (11) (2023)
Arundhathi Dev, Meenakshi Vachher, Chandra Prakash Prasad
β-catenin inhibitors in cancer therapeutics: intricacies and way forward. Bioengineered 14 (1) (2023)
Chandra Prakash Prasad, Satyendra Chandra Tripathi, Manish Kumar, Purusottam Mohapatra
Passage number of cancer cell lines: Importance, intricacies, and way-forward. Biotechnology and bioengineering (2023)
Akanksha Kashyap, Sheikh Mohammad Umar, Arundhathi Dev J R, Sandeep R Mathur, Ajay Gogia, Atul Batra, S V S Deo, Chandra Prakash Prasad
Combination of 3PO analog PFK15 and siPFKL efficiently suppresses the migration, colony formation ability, and PFK-1 activity of triple-negative breast cancers by reducing the glycolysis. Journal of cellular biochemistry (2023)
Chandra Prakash Prasad, Ajay Gogia, Atul Batra
Essential role of aerobic glycolysis in epithelial-to-mesenchymal transition during carcinogenesis. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 24 (10) (2022)
J R Dev Arundhathi, Sandeep R Mathur, Ajay Gogia, S V S Deo, Purusottam Mohapatra, Chandra Prakash Prasad
Metabolic changes in triple negative breast cancer-focus on aerobic glycolysis. Molecular biology reports 48 (5) (2021)
Chandra Prakash Prasad, Shivendra Kumar Chaurasiya, William Guilmain, Tommy Andersson
WNT5A signaling impairs breast cancer cell migration and invasion via mechanisms independent of the epithelial-mesenchymal transition. Journal of experimental & clinical cancer research : CR 35 (1) (2016)

Chandra Prakash Prasad.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Chandra Prakash Prasad